Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Straight talk with...Michel Sidibé


Last month, Michel Sidibé assumed his new role as executive director of UNAIDS, the United Nations agency created more than a decade ago to foster global leadership in the response to the AIDS pandemic. The agency—based in Geneva, Switzerland and cosponsored by ten other UN agencies, including the World Health Organization (WHO) and the World Bank—has received huge praise for helping to increase spending for AIDS and working with civil rights groups to lower the price of antiretroviral drugs. But UNAIDS has also faced criticism for failing to remove legal roadblocks to treatment and prevention of the disease in certain countries and for kowtowing to its cosponsors, which have competed for resources and recognition. Sidibé, a citizen of Mali, joined UNAIDS in 2001. While at the agency, he has overseen and coordinated HIV/AIDS treatment and prevention efforts in UN member countries and implemented methods to evaluate the agency's efforts. Sidibé discussed his new goals as executive director of UNAIDS with Prashant Nair.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Author information

Authors and Affiliations


Rights and permissions

Reprints and Permissions

About this article

Cite this article

Nair, P. Straight talk with...Michel Sidibé. Nat Med 15, 130–131 (2009).

Download citation

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing